6 months ago
SANA
AnalystsEmily BodnarEmily Bodnar's Stock Forecasts
AnalystsEmily Bodnar
Sectors:
Analyst Ranking
Bottom 1%
#4931 out of 4935 analysts
Average Return
-21.71%
Win Rate
26%76 out of 290
Risk vs Reward
Poor
Good
Emily Bodnar's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Gracell Biotechnologies IncGRCL | +372.38% | $2.10 | $9.92 | 2023-02-16 - 2023-12-26 | Buy |
Gracell Biotechnologies IncGRCL | +322.13% | $2.35 | $9.92 | 2023-02-06 - 2023-12-26 | Buy |
Gracell Biotechnologies IncGRCL | +254.29% | $2.80 | $9.92 | 2023-05-26 - 2023-12-26 | Buy |
Olema Pharmaceuticals IncOLMA | +234.19% | $3.89 | $13.00 | 2023-03-10 - 2024-03-08 | Buy |
Nkarta IncNKTX | +216.80% | $3.84 | $12.17 | 2023-03-17 - 2024-03-15 | Buy |
Emily Bodnar Analyst Color
Get additional color on Emily Bodnar's coverage of popular stocks
2 years ago
FEMY
Emily Bodnar's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Rapt Therapeutics IncRAPT | 2 | Buy | $27.00 | +213.23% | Maintains | 2 days ago |
Jasper Therapeutics IncJSPR | 10 | Buy | $20.00 | +463.38% | Maintains | 4 days ago |
Nextcure IncNXTC | 9 | Buy | $3.00 | +541.03% | Reiterates | 11 days ago |
Femasys IncFEMY | 24 | Buy | $12.00 | +1,164.49% | Reiterates | 17 days ago |
Arcellx IncACLX | 13 | Buy | $115.00 | +67.01% | Reiterates | a month ago |
Artiva Biotherapeutics IncARTV | 1 | Buy | $12.00 | +570.39% | Assumes | a month ago |
Agenus IncAGEN | 12 | Buy | $25.00 | +322.30% | Upgrades | a month ago |
Anaptysbio IncANAB | 9 | Buy | $38.00 | +45.65% | Upgrades | a month ago |
Sab Biotherapeutics IncSABS | 1 | Buy | $10.00 | +300.00% | Assumes | 2 months ago |
Olema Pharmaceuticals IncOLMA | 19 | Buy | $30.00 | +518.56% | Reiterates | 2 months ago |
Sana Biotechnology IncSANA | 10 | Buy | $11.00 | +170.94% | Reiterates | 3 months ago |
Briacell Therapeutics CorpBCTX | 14 | Buy | $32.00 | +1,445.89% | Reiterates | 3 months ago |
Transcode Therapeutics IncRNAZ | 17 | Buy | $280.00 | +3,011.11% | Maintains | 3 months ago |
Vtv Therapeutics IncVTVT | 1 | Buy | $36.00 | +105.71% | Initiates Coverage On | 3 months ago |
Connect Biopharma Holdings LtdCNTB | 6 | Buy | $8.00 | +595.65% | Reiterates | 3 months ago |
Io Biotech IncIOBT | 13 | Buy | $12.00 | +757.14% | Reiterates | 3 months ago |
Genelux CorpGNLX | 7 | Buy | $30.00 | +772.09% | Reiterates | 3 months ago |
Acrivon Therapeutics IncACRV | 11 | Buy | $19.00 | +1,307.41% | Reiterates | 3 months ago |
Nkarta IncNKTX | 13 | Buy | $18.00 | +900.00% | Reiterates | 3 months ago |
Imunon IncIMNN | 13 | Buy | $14.00 | +2,053.85% | Reiterates | 4 months ago |
Atossa Therapeutics IncATOS | 13 | Buy | $7.00 | +688.29% | Reiterates | 4 months ago |
Context Therapeutics IncCNTX | 9 | Buy | $5.00 | +646.27% | Reiterates | 4 months ago |
Mink Therapeutics IncINKT | 12 | Buy | $35.00 | +352.78% | Reiterates | 4 months ago |
Arcus Biosciences IncRCUS | 5 | Buy | $24.00 | +151.57% | Upgrades | 5 months ago |
Agios Pharmaceuticals IncAGIO | 1 | Buy | $58.00 | +46.72% | Reiterates | 5 months ago |
Tenaya Therapeutics IncTNYA | 1 | Buy | $18.00 | +2,516.28% | Reiterates | 5 months ago |
Novocure LtdNVCR | 18 | Buy | $38.00 | +105.85% | Reiterates | 6 months ago |
Acelyrin IncSLRN | 13 | Hold | $6.00 | +164.32% | Maintains | 6 months ago |
Geron CorpGERN | 3 | Buy | $9.00 | +552.17% | Reiterates | 7 months ago |
Purple Biotech LtdPPBT | 13 | Buy | $33.00 | +1,209.52% | Reiterates | 8 months ago |
Ventyx Biosciences IncVTYX | 13 | Hold | $6.00 | +111.27% | Reiterates | 8 months ago |
Gracell Biotechnologies IncGRCL | 6 | Hold | $10.00 | N/A | Downgrades | 2 years ago |
Dice Therapeutics IncDICE | 8 | Hold | $48.00 | N/A | Reiterates | 2 years ago |
Sqz Biotechnologies CoSQZB | 2 | Hold | N/A | N/A | Downgrades | 3 years ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.